- Pain detection app developers PainChek (PCK) has expanded its presence in New Zealand through a partnership with Medi-map
- The Medi-map platform is the leading medication management software for aged care providers in New Zealand
- Medi-map has around 80 percent of the New Zealand residential aged care market under contract
- Under the partnership, Medi-map will promote PainChek to their aged care clients andPainChek’s results will also integrate into the platform
- The New Zealand market presents a strong market opportunity, with almost 40,000 residents in aged care and 70,000 people living with dementia
- On market close, PainChek shares fell 4.44 percent and are trading for 8.6 cents per share
